Internal Seminar: CRSPR-Cas9 Mediated Genome Editing Offers Cure For HIV
On January 25th, Mr. Harmand A. Hama, the Head of the Biology Department at Tishk International University (TIU), presented a seminar regarding the potential of CRISPR-Cas9 genome editing technology in offering a cure for HIV. Through the study conducted on animal models, it was demonstrated that the CRISPR-Cas9 system can accurately target and eliminate the HIV-1 virus from infected cells.
The CRISPR-Cas9 system has revolutionized genome editing and provides scientists with the ability to make precise modifications to DNA sequences. In the study, the researchers utilized the CRISPR-Cas9 system to target and eliminate the HIV-1 virus from the genome of infected cells. The findings revealed a significant reduction in the virus in the animal models, and in some cases, complete elimination of the virus.
This groundbreaking research provides hope for the development of a cure for HIV, a condition affecting millions of people worldwide. By eliminating the virus from infected cells using CRISPR-Cas9 genome editing technology, it could potentially lead to a functional cure for HIV, where the virus is no longer detectable in the body and the patient does not require lifelong treatment.
It’s important to note that this research is in its preliminary stages, and further studies are necessary to confirm the safety and effectiveness of this approach in human patients. Nevertheless, the outcomes of this study are highly encouraging and could pave the way for the development of new HIV therapies.
